OTC · CIK 0001618835
EVFM Evofem Biosciences, Inc.
Insider trading from SEC Form 4. Last filing Jan 12, 2024. Close $0.01 on Oct 13, 2026, +17% from the 52-week low and -46% from the high.
In brief
Evofem Biosciences, Inc. (EVFM) has 3 SEC Form 4 filings on file from 3 insiders, the latest filed on Jan 12, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
2 open-market trades have been scored at EVFM. The newest: Yan Zhang (CFO) sold $4 of stock on Jan 12, 2024, filed Jan 12, 2024, scored 42 (moderate). The largest of the 2 shown: Kim P. Kamdar (director) sold $6 on Dec 21, 2023, scored 35 (weak).
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Evofem Biosciences, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Yan Zhang CFO sell | $4 104 shares | -100% | +3% from low-100% from high | |
| 35Weak | Kim P. Kamdar director sell | $6 10 shares | -100% | 0% from low-99% from high |
Transactions
Every row filed, 3 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Yan Zhang CFO | SOpen-market sale Common Stock | -104 | $0.04 | $4 | 0 | Jan 12, 2024 |
| Dec 21, 2023 | Kim P. Kamdar director | SOpen-market sale Common Stock | -10 | $0.62 | $6 | 0 | Dec 22, 2023 |
| Dec 31, 2022 | Saundra L Pelletier Chief Executive Officer | DDisposition to issuer Common Stock | -50,000 | $0.00 | $0 | 186,722 | Apr 26, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Kim P. Kamdardirector
- Saundra L PelletierChief Executive Officer
- Yan ZhangCFO
Questions about EVFM
Answered from the filings on this page, as of the latest one.
Are insiders buying EVFM?
No. In the last 90 days no insider at Evofem Biosciences, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade EVFM on the open market?
Yan Zhang (CFO) sold $4 of EVFM on Jan 12, 2024 and filed the Form 4 on Jan 12, 2024. InsiderTell scored 42 (moderate).
How many insiders file Form 4 at Evofem Biosciences, Inc.?
3 people have filed a Form 4 at Evofem Biosciences, Inc., among them Kim P. Kamdar (director), Saundra L Pelletier (Chief Executive Officer), Yan Zhang (CFO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.